Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Loss of laminin-γ1 in pericytes impairs microvascular function and cognition.

Created on 28 Aug 2026

Authors

Jingsong Ruan, Ava Nasrollahi, Cecilia Martin, Meisam Asgari, Andy Y Shih, Yao Yao

Published in

Cell reports. Volume 45. Issue 9. Pages 117904. Aug 27, 2026. Epub Aug 27, 2026.

Abstract

Blood-brain barrier (BBB) disruption correlates with lesion burden and cognitive dysfunction in cerebral small vessel disease (CSVD). Laminin, highly produced by pericytes in the brain, maintains BBB integrity. However, it remains unclear if laminin dysregulation contributes to the pathogenesis of CSVD. Here, we show that mice lacking laminin-γ1 in pericytes, smooth muscle cells, and fibroblasts (PKO) develop age-dependent BBB disruption via both paracellular and transcellular mechanisms. In contrast, loss of laminin-γ1 in smooth muscle cells or fibroblasts fails to affect BBB integrity. In addition, the PKO mice exhibit pericyte loss, thickened basal lamina, increased brain stiffness, followed by brain clearance defect, synaptic loss, and cognitive impairment. Together, these results demonstrate that loss of pericytic laminin-γ1 induces progressive vascular dysfunction and several features of CSVD, including brain stiffness, synaptic loss, and cognitive impairment, highlighting a potential role of laminin-γ1 dysregulation in the pathogenesis of CSVD.

PMID:
42658675
Bibliographic data and abstract were imported from PubMed on 28 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 23
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement